Access to Medicine

Constituency statement for Knowledge Ecology International, Health Action International, Oxfam, and Public Services International: Strengthening WHO preparedness for and response to health emergencies

Posted on by Thiru

On 24 May 2022, I delivered the following constituency statement on behalf of Knowledge Ecology International, Health Action International, Oxfam, and Public Services International on the following topic: “16.2 – Strengthening WHO preparedness for and response to health emergencies” at… Continue Reading →

White smoke emerges from WHO negotiations on a resolution on Strengthening clinical trials to provide high-quality evidence on health interventions and to improve research quality and coordination

Posted on by Thiru

At around 10 PM on Friday evening, 20 May 2022, member states of the World Health Organization (WHO) negotiating on a resolution titled, Strengthening clinical trials to provide high-quality evidence on health interventions and to improve research quality and coordination,… Continue Reading →

NIH Questioned about Xtandi and March-in Rights during Congressional Hearing

Posted on by Claire Cassedy

On Wednesday May 11, 2022, the National Institutes of Health (NIH) was asked about Xtandi and march-in rights during a Congressional hearing. The House Appropriations Committee held a hearing on the FY2023 Budget Request for the NIH, and Representative Mark… Continue Reading →

KEI Comments Regarding NIH Prospective Exclusive License to Georgetown University for Pancreatic Cancer Diagnostic

Posted on by KEI Staff

On April 28, 2022, Knowledge Ecology International (KEI) provided comments on the latest National Institutes of Health (NIH) Federal Register notice concerning licensing, the “Prospective Grant of an Exclusive Patent License: Development of Diagnostic for Imaging and Early Detection of… Continue Reading →

Amicus Brief of Professor Brook Baker on the human right principles and TRIPS-compliant interpretation of the compulsory license petition filed by KEI in the Dominican Republic

Posted on by Luis Gil Abinader

Last week, Professor Brook Baker filed an Amicus Brief responding to four of the arguments made by Pfizer against the compulsory license requested by KEI in the Dominican Republic to allow the distribution of the generic version of Paxlovid. His… Continue Reading →

KEI Comments Regarding NIH Exclusive License to Syncopation for CAR T Therapy

Posted on by KEI Staff

Knowledge Ecology International (KEI) filed comments with the National Institutes of Health (NIH) on March 16, 2022 regarding the “Prospective Grant of an Exclusive Patent License: Development and Commercialization of Chimeric Antigen Receptor T-Cell Therapies (CAR-T) That are Specific to… Continue Reading →